Trials / Completed
CompletedNCT05492552
Cardiovascular Function and Physical Activity in COVID-19
Cardiovascular Implications and Physical Activity in Middle-age and Older People With a History of Coronavirus 2019 (COVID-19)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 124 (actual)
- Sponsor
- Coventry University · Academic / Other
- Sex
- All
- Age
- 50 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to a) assess how coronavirus 2019 (COVID-19) affects cardiac function in middle age and older adults and b) assess if a physical activity intervention (increased daily step count by 2,000) can affect cardiac function in a population with a history of COVID-19.
Detailed description
Cardiac function will be assessed by obtaining arterial stiffness, comprehensive echocardiography measurements and haemodynamic monitoring. Arterial stiffness will assess primarily pulse wave velocity (PWV) and echocardiography. Graded cardiopulmonary exercise stress testing coupled with non-invasive gas exchange and haemodynamic monitoring will also be performed. Physical activity will be assessed objectively using pedometers and accelerometry. Quality of life, sleep/ circadian rhythm, fatigue, anxiety and depression will be measured using the validated Short-Form-36 (SF-36) questionnaire, Pittsburgh Sleep scale (PSQI), Chalder fatigue (CF) scale and the Depression, Anxiety and Stress Scale (DASS-21).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Active-at-home-HF | Increase daily step count by 2,000 and weekly telephone calls. |
Timeline
- Start date
- 2022-04-07
- Primary completion
- 2023-05-11
- Completion
- 2023-05-11
- First posted
- 2022-08-08
- Last updated
- 2023-08-31
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05492552. Inclusion in this directory is not an endorsement.